Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-001566
Filing Date
2025-03-31
Accepted
2025-03-31 12:20:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 602868
2 form424b5_001.jpg GRAPHIC 6989
  Complete submission text file 0001641172-25-001566.txt   613754
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269157 | Film No.: 25790412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)